Latest News of ITCI
Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results
By Yahoo! Finance |
2 weeks ago
Intra-Cellular Therapies' shares surged 14% after its latest quarterly results, with analysts forecasting a 52% revenue increase by 2025. Earnings per share are expected to rise, indicating a bullish ...
Intra-Cellular Therapies, Inc. (ITCI): Among the Most Promising Mid-Cap Stocks According to Hedge Funds
By Yahoo! Finance |
1 month ago
The article discusses the top mid-cap stocks favored by hedge funds, focusing on Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), ranking 8th....
Analysts Expect Breakeven For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Before Long
By Yahoo! Finance |
3 months ago
Intra-Cellular Therapies, Inc., a biopharmaceutical company, is approaching breakeven with analysts predicting profitability in 2025 after a loss of US$140m in the previous year. The company's debt-fr...